Predicting pancreatic ductal adenocarcinoma using artificial intelligence analysis of pre-diagnostic computed tomography images
Cancer Biomarkers · 14.02.2022 · 33 (2) · 211-217
DOI: 10.3233/cbm-210273 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Biomarkers, erschienen am 14.02.2022. Verfasst von Touseef Ahmad Qureshi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Hauptthemen laut MEDLINE: Artificial Intelligence. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Early stage diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC) is challenging due to the lack of specific diagnostic biomarkers. However, stratifying individuals at high risk of PDAC, followed by monitoring their health conditions on regular basis, has the potential to allow diagnosis at early stages. OBJECTIVE: To stratify high risk individuals for PDAC by identifying predictive features in pre-diagnostic abdominal Computed Tomography (CT) scans. METHODS: A set of CT features, potentially predictive of PDAC, was identified in the analysis of 4000 raw radiomic parameters extracted from pancreases in pre-diagnostic scans. The naïve Bayes classifier was then developed for automatic classification of CT scans of the pancreas with high risk for PDAC. A set of 108 retrospective CT scans (36 scans from each healthy control, pre-diagnostic, and diagnostic group) from 72 subjects was used for the study. Model development was performed on 66 multiphase CT scans, whereas external validation was performed on 42 venous-phase CT scans. RESULTS: The system achieved an average classification accuracy of 86% on the external dataset. CONCLUSIONS: Radiomic analysis of abdominal CT scans can unveil, quantify, and interpret micro-level changes in the pre-diagnostic pancreas and can efficiently assist in the stratification of high risk individuals for PDAC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
- Gastroenterology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
- Department of Radiology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
- Department of Radiology, Chaoyang Hospital, Beijing, China.
- Southern California Kaiser Permanente Medical Center, Los Angeles, CA, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Qureshi, T. A., Gaddam, S., Wachsman, A. M., Wang, L., Azab, L., Asadpour, V., Chen, W., Xie, Y., Wu, B., Pandol, S. J., & Li, D. (2022). Predicting pancreatic ductal adenocarcinoma using artificial intelligence analysis of pre-diagnostic computed tomography images. Cancer Biomarkers, 33(2), 211-217. https://doi.org/10.3233/cbm-210273
Vancouver
Qureshi TA, Gaddam S, Wachsman AM, Wang L, Azab L, Asadpour V, et al. Predicting pancreatic ductal adenocarcinoma using artificial intelligence analysis of pre-diagnostic computed tomography images. Cancer Biomarkers. 2022;33(2):211-217. doi:10.3233/cbm-210273
BibTeX
@article{Qureshi2022,
author = {Qureshi, Touseef Ahmad and Gaddam, Srinivas and Wachsman, Ashley Max and Wang, Lixia and Azab, Linda and Asadpour, Vahid and Chen, Wansu and Xie, Yibin and Wu, Bechien and Pandol, Stephen Jacob and Li, Debiao},
title = {Predicting pancreatic ductal adenocarcinoma using artificial intelligence analysis of pre-diagnostic computed tomography images},
journal = {Cancer Biomarkers},
year = {2022},
volume = {33},
number = {2},
pages = {211--217},
doi = {10.3233/cbm-210273}
}
EUVIMED